1、2026 Pharma Trends Outlook:AI Governance and an Interdisciplinary Industry2026 Pharma Trends Outlook:AI Governance and an Interdisciplinary Industry 2WelcomeCompliance in the Age of AIInterdisciplinary Integration of Tech and PharmaHumanising a Digital WorkforceTo Specialise or Not To Specialise:The

2、 Modern Pharma Outsourcing PlaybookValue Chain Resilience Amidst GeopoliticsManufacturing Patient Empowerment and AccessibilitySecond Mover Advantage?Breakthrough Therapies and Breakthrough StrategiesRecalibrating Pharmaceutical Pricing StrategiesEvolving the Green Pipeline:The Future of Sustainabil

3、ity in PharmaExecutive SummaryContributorsReferencesContents359121621263236394447502026 Pharma Trends Outlook:AI Governance and an Interdisciplinary Industry 3WelcomeThank you for downloading the 2026 Pharma Trends Outlook Report,our annual CPHI Online publication heralding in the top challenges and

4、 opportunities facing the pharmaceutical supply chain for the year ahead.In these reports,we reflect on the past year of dynamic innovation,strategic priorities,and market pressures to inform expectations for the next year.Our report last year cited many disruptions to the pharmaceutical supply chai

5、n,including legislations like the BIOSECURE Act,ongoing conflicts in Gaza and Ukraine,and changing partnership structures between vendors and sponsors,to hail some of the biggest shifts the industry has witnessed to date.As we start 2026,how have these predictions shaped the next wave of changes?As

6、one of the premier B2B event platforms for the pharmaceutical industry,we at CPHI are continuously aware of the evolution of partnership models within the pharmaceutical supply chain.As many vendors make the move towards a one-stop-shop,end-to-end structure,where does that leave companies looking fo